OTTAWA (Reuters) - The Federal Court of Canada rejected on Thursday a bid by generic drugmaker Novapharm Ltd to be allowed to market a generic version of Pfizer Inc's erectile dysfunction drug Viagra.
The court said Novapharm should not be allowed to introduce a generic version until Pfizer's Canadian patent expires in 2014. The court rejected Novapharm's allegation that the patent is invalid.
Novapharm is part of Teva Pharmaceutical Industries Ltd
WASHINGTON (Reuters) -- U.S. Treasury pay czar Kenneth Feinberg has approved compensation plans for several firms receiving assistance from Uncle Sam.
The bubble has burst and the economy is bottoming out. So why are Americans still hesitant to buy new homes? Full Article
Ever the contrarian, fund manager Maura Shaughnessy finds ways to make money amid the market meltdown -- even if it means kicking executives in the shin. Full Article
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
